Infiltration of Epstein-Barr virus-harboring lymphocytes occurs in a large subset of bladder cancers

International Journal of Urology

Volumn 15, Issue 5, 2008, Pages 429-434

  Abe, Takashige ^a   Shinohara, Nobuo ^a   Tada, Mitsuhiro ^b   Harabayashi, Toru ^a   Sazawa, Ataru ^a   Maruyama, Satoru ^a   Moriuchi, Tetsuya ^b   Takada, Kenzo ^b   Nonomura, Katsuya ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Bladder cancer; BZLF1; Epstein Barr virus

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; IMMEDIATE EARLY PROTEIN BZLF1; TRANSFORMING GROWTH FACTOR BETA1; VIRUS RNA;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR ASSOCIATED LEUKOCYTE; VIRUS CARCINOGENESIS;

AGED; AGED, 80 AND OVER; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; JAPAN; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; URINARY BLADDER NEOPLASMS;

EID: 43049112785     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.02030.x     Document Type: Article

References (25)

1. Anagnostopoulos I, Hummel M, Kreschel C, Stein H. Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood 1995 85 : 744 50.
2. Niedobitek G, Agathanggelou A, Herbst H, Whitehead L, Wright DH, Young LS. Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells. J. Pathol. 1997 182 : 151 9.
3. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964 1 : 702 3.
4. Veltri RW, Shah SH, McClung JE, Klingberg WG, Sprinkle PM. Epstein-Barr virus, fatal infectious mononucleosis, and Hodgkin's disease in siblings. Cancer 1983 51 : 509 20.
5. Weiss LM, Movahed LA, Warnke RA, Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N. Engl. J. Med. 1989 320 : 502 6.
6. Young L, Alfieri C, Hennessy K et al. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N. Engl. J. Med. 1989 321 : 1080 5.
7. Hamilton-Dutoit SJ, Pallesen G, Franzmann MB et al. AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization. Am. J. Pathol 1991 138 : 149 63.
8. zur Hausen H, Schulte-Holthausen H, Klein G et al. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 1970 228 : 1056 8.
9. Takada K. Epstein-Barr virus and gastric carcinoma. Mol. Pathol. 2000 53 : 255 61.
10. Labrecque LG, Barnes DM, Fentiman IS, Griffin BE. Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res. 1995 55 : 39 45.
11. Bonnet M, Guinebretiere JM, Kremmer E et al. Detection of Epstein-Barr virus in invasive breast cancers. J. Natl. Cancer Inst. 1999 91 : 1376 81.
12. Wong MP, Chung LP, Yuen ST et al. In situ detection of Epstein-Barr virus in non-small cell lung carcinomas. J. Pathol. 1995 177 : 233 40.
13. Sugawara Y, Mizugaki Y, Uchida T et al. Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression. Virology 1999 256 : 196 202.
14. Gazzaniga P, Vercillo R, Gradilone A et al. Prevalence of papillomavirus, Epstein-Barr virus, cytomegalovirus, and herpes simplex virus type 2 in urinary bladder cancer. J. Med. Virol. 1998 55 : 262 7.
15. Chuang CK, Liao SK. Epstein-Barr virus infection in urothelial transitional cell carcinoma tissues. BJU Int. 2004 93 : 495 8.
16. Sobin LH, Wittekind CH (eds). TNM Classification of Malignant Tumors, 5th edn. Wiley-Liss, New York, 1997.
17. Mostofi FK, Davis CJ, Sesterhenn IA. Histological Typing of Urinary Bladder Tumors, 2nd edn. Springer Verlag, Berlin, 1999.
18. Abe T, Tada M, Shinohara N et al. Establishment and characterization of human urothelial cancer xenografts in SCID mice. Int. J. Urol. 2005 13 : 47 57.
19. Klein SC, Kube D, Abts H, Diehl V, Tesch H. Promotion of IL8, IL10, TNF alpha and TNF beta production by EBV infection. Leuk. Res. 1996 20 : 633 6.
20. Jabs WJ, Wagner HJ, Maurmann S, Hennig H, Kreft B. Inhibition of macrophage inflammatory protein-1 alpha production by Epstein-Barr virus. Blood 2002 99 : 1512 16.
21. Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan TA, Mosmann TR. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 1990 248 : 1230 4.
22. Imai S, Nishikawa J, Takada K. Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J. Virol. 1998 72 : 4371 8.
23. Lawrence DA. Transforming growth factor-beta: a general review. Eur. Cytokine Netw. 1996 7 : 363 74.
24. di Renzo L, Altiok A, Klein G, Klein E. Endogenous TGF-beta contributes to the induction of the EBV lytic cycle in two Burkitt lymphoma cell lines. Int. J. Cancer 1994 57 : 914 19.
25. Fahmi H, Cochet C, Hmama Z, Opolon P, Joab I. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway. J. Virol. 2000 74 : 5810 18.